Welfare consequences for people diagnosed with attention deficit hyperactivity disorder (ADHD): A matched nationwide study in Denmark.

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Poul JennumErik Simonsen

Abstract

There is insufficient data regarding the excess direct and indirect costs associated with attention deficit hyperactivity disorder (ADHD). Using the Danish National Patient Registry (2002-2016), we identified 83,613 people of any age with a diagnosis of ADHD or who were using central-acting medication against ADHD (primarily methylphenidate, with at least two prescriptions) and matched them to 334,446 control individuals. Additionally, 18,959 partners of patients aged ≥18 years with ADHD were identified, and compared with 74,032 control partners. Direct costs were based on data from the Danish Ministry of Health. Information about the use and costs of drugs were obtained from the Danish Medicines Agency. The frequencies of visits and hospitalizations, and costs of general practice were derived from data from the National Health Security. Indirect costs were obtained from Coherent Social Statistics. The average annual health care costs for people with ADHD and their partners were, respectively, €2636 and €477 higher than those of the matched controls. A greater percentage of people with ADHD and their partners compared with respective control subjects received social services (sick pay or disability pension). Those with ADHD had...Continue Reading

Citations

Feb 8, 2021·Neuroscience and Biobehavioral Reviews·Stephen V FaraoneYufeng Wang
Mar 29, 2021·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Heidi Taipale, Jari Tiihonen
Jun 12, 2021·Journal of the American Academy of Child and Adolescent Psychiatry·Mariya V CherkasovaLily Hechtman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.